A recent study reveals that individuals who discontinue blockbuster slimming jabs like Mounjaro or Wegovy may regain shed pounds at a significantly accelerated pace than those who stop conventional diet and exercise regimens.
Research printed in a major health publication demonstrates that while obese individuals often shed substantial amounts of their total mass while using the jabs, the mass is regained at an estimated rate of 0.8 kg per month after stopping.
"Users purchasing these drugs should be informed of the risk of fast weight regain when the therapy concludes," cautioned researcher Dr. Susan Jebb.
This pace of regain implies a return to pre-treatment weight within about a year and a half.
Analyzing Approaches
The analysis, which reviewed 37 of trials involving thousands of participants, contrasted the effects of the injectable medications with other pills.
Scientists emphasize that people who shed pounds through lifestyle changes alone generally experience a less rapid creep back—perhaps 0.1 kg a month—post-intervention.
The Reason for the Quick Rebound
Experts propose the mechanism of the drugs is key to understanding the accelerated weight return.
These medications mimic a natural hormone called glucagon-like peptide-1, which controls hunger.
"Artificially providing the hormone levels several times higher than the body's typical production might result in the system to generate a reduced amount of its endogenous hormone, and could diminish responsiveness to its effects," explained Dr. Adam Collins, a dietetics expert.
"Stopping of this medication means hunger is uncontrolled, making excessive eating a significant risk."
An Ongoing Condition?
Medical guidelines recommend the injections for individuals with obesity-related health risks, alongside recommended lifestyle changes.
Professionals argue that, considering the high risk of weight regain, the therapy might need to be long-term.
This opinion is reinforced by drug manufacturers, who say that the results "highlight the chronic nature of excess weight," akin to managing diseases like high blood pressure.
User Testimonies
People who have stopped the medication report a powerful resurgence of appetite.
"It was like something flipping and you become starving," recalled an individual.
This challenge is exacerbated if users have not adopted lasting lifestyle or habit changes during therapy.
Widespread Adoption
Figures indicate that millions of people in the UK have used these injections in the last 12 months, with interest being substantial.
- Adoption is higher among females than men.
- The 40s and 50s demographic shows the highest level of interest.
- A large proportion obtain the medications through private healthcare rather than the NHS.
In conclusion, clinicians caution that while GLP-1 drugs are potent tools for shedding pounds, they are not a magic cure and lasting health benefits likely depends on combined behavioural management.
